Lys89

Javascript is not enabled on this browser. This site will not work properly without Javascript.

Home > Acetylation Site Page: > Lys89 - ACOX1 (human)

Site Information
PDEIMWFkKLHLVNF SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 461313

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 )
Disease tissue studied:	liver cancer ( 1 ) , hepatocellular carcinoma ( 1 )
Relevant cell line - cell type - tissue:	HepG2 (hepatic) ( 1 )

References
1	Mitchell J (2005) CST Curation Set: 867; Year: 2005; Biosample/Treatment: cell line, HepG2/TSA; Disease: hepatocellular carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK Curated Info

Developed with grants from

and literature mining with Linguamatics

PhosphoSite, created by Cell Signaling Technology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.